0001209191-19-025198.txt : 20190417
0001209191-19-025198.hdr.sgml : 20190417
20190417212820
ACCESSION NUMBER: 0001209191-19-025198
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190415
FILED AS OF DATE: 20190417
DATE AS OF CHANGE: 20190417
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CASTANEDA MARK
CENTRAL INDEX KEY: 0001247157
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38594
FILM NUMBER: 19754335
MAIL ADDRESS:
STREET 1: 1304B 7TH AVE N.
CITY: NASHVILLE
STATE: TN
ZIP: 37208
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tilray, Inc.
CENTRAL INDEX KEY: 0001731348
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1920 EASTLAKE AVENUE E.
CITY: SEATTLE
STATE: WA
ZIP: 98102
BUSINESS PHONE: 2064329325
MAIL ADDRESS:
STREET 1: 1920 EASTLAKE AVENUE E.
CITY: SEATTLE
STATE: WA
ZIP: 98102
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-04-15
0
0001731348
Tilray, Inc.
TLRY
0001247157
CASTANEDA MARK
1100 MAUGHAN ROAD
NANAIMO
A1
V9X IJ2
BRITISH COLUMBIA, CANADA
0
1
0
0
CFO, Secretary, Treasurer
Class 2 Common Stock
2019-04-15
4
M
0
10000
7.76
A
18205
D
Class 2 Common Stock
2019-04-15
4
S
0
10000
51.72
D
8205
D
Stock Option (Right to Buy)
7.76
2019-04-15
4
M
0
10000
0.00
D
2028-05-20
Class 2 Common Stock
10000
520000
D
The stock option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.62 to $51.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote 3 to this Form 4.
The shares vest at a rate of 50% of the total shares on July 18, 2019 (the "Vesting Date"), with the remaining 50% of the total shares vesting upon the one-year anniversary of the Vesting Date, provided that the Reporting Person remains in Continuous Service (as defined in the Company's 2018 Equity Incentive Plan) until such date.
/s/ Alan Hambelton, Attorney-in-fact
2019-04-17